RBC Europe’s NuVasive, Inc. NUVA Stock Holding History

RBC Europe’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,000	Closed	-$175K	–	1176
2017 Q4	$175K	Hold	3,000	–	–	0.02%	265
2017 Q3	$166K	Buy	+3,000	New	+$199K	0.02%	273

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RBC Europe's NUVA Position: Q1 2018 in Review

RBC Europe sold out of NuVasive, Inc. (NUVA) in Q1 2018, closing a stake of 3,000 shares — an estimated $175K sold.

RBC Europe first reported a position in NUVA in Q3 2017 and held it in 2 quarters. The position peaked at $175K in Q4 2017. 279 funds tracked by Wall St. Rank hold NUVA as of Q1 2018.

RBC Europe reported no remaining NuVasive, Inc. position as of Q1 2018 after selling out during the quarter.
RBC Europe sold 3,000 NuVasive, Inc. shares in Q1 2018, an estimated $175K.
RBC Europe first reported a position in NuVasive, Inc. in Q3 2017 and held it in 2 quarters.
RBC Europe's NuVasive, Inc. position peaked at $175K in Q4 2017.
279 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2018.

Based on RBC Europe's 13F filing for Q1 2018, filed 9 Nov 2023.